Wan Li
Impact in
- Oncology top 10%
- Viral-associated cancers and disorders
- Chemokine receptors and signaling
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Oncology 10
- Viral-associated cancers and disorders 9
-
- interferon and immune responses 2
- Co-authors
- Chun Lu (10 shared papers)Shou‐Jiang Gao (9 shared papers)Jie Qin (2 shared papers)Qin Yan (7 shared papers)Zhigang Gao (1 shared paper)Shaowei Song (1 shared paper)Kejian Guo (1 shared paper)Changling Li (1 shared paper)
- Journals
- Cell Death and Differentiation (3 papers)Journal of Virology (2 papers)PLoS Pathogens (2 papers)Applied Materials Today (1 paper)International Journal of Oncology (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Wan Li
18 papers receiving 576 citations
Peers
Comparison fields: 5 of 75
- Oncology 235
- Cancer Research 116
- Immunology 127
- Epidemiology 119
- Molecular Biology 196
Countries citing papers authored by Wan Li
This map shows the geographic impact of Wan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan Li more than expected).
Fields of papers citing papers by Wan Li
This network shows the impact of papers produced by Wan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan Li. The network helps show where Wan Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Wan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 77 | |
| 2 | 2015 | 72 | |
| 3 | 2017 | 70 | |
| 4 | 2015 | 54 | |
| 5 | 2017 | 54 | |
| 6 | 2019 | 50 | |
| 7 | 2019 | 39 | |
| 8 | 2013 | 38 | |
| 9 | 2010 | 33 | |
| 10 | 2020 | 14 | |
| 11 | 2018 | 14 | |
| 12 | 2010 | 13 | |
| 13 | 2017 | 12 | |
| 14 | 2020 | 12 | |
| 15 | 2020 | 11 | |
| 16 | 2022 | 7 | |
| 17 | 2013 | 5 | |
| 18 | 2012 | 5 |
About Wan Li
Wan Li is a scholar working on Oncology, Immunology, Epidemiology, Physiology and Molecular Biology, having authored 18 papers that have together received 580 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (9 papers), Histiocytic Disorders and Treatments (4 papers), Cytomegalovirus and herpesvirus research (4 papers), Lymphoma Diagnosis and Treatment (3 papers), Parvovirus B19 Infection Studies (2 papers), interferon and immune responses (2 papers), Extracellular vesicles in disease (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Oncology (235 citations), Cancer Research (116 citations), Immunology (127 citations), Epidemiology (119 citations) and Molecular Biology (196 citations). Wan Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Chun Lu, Shou‐Jiang Gao, Jie Qin, Qin Yan, Zhigang Gao, Shaowei Song, Kejian Guo, Changling Li, Zhiqiang Bai and Cong Wang. Their work appears in journals such as Cell Death and Differentiation, Journal of Virology, PLoS Pathogens, Applied Materials Today and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.